How much revenue did Stereotaxis generate this year?
Stereotaxis has achieved a revenue of 27.08 M USD this year.
Stereotaxis Revenue 2024
Stereotaxis Revenue
27.08 M USD
Ticker
STXS
ISIN
US85916J4094
WKN
A1J09L
In 2024, Stereotaxis's sales reached 27.08 M USD, a 1.16% difference from the 26.77 M USD sales recorded in the previous year.
The Stereotaxis Revenue history
| YEAR | REVENUE (undefined USD) | GROSS MARGIN (%) |
|---|---|---|
| 2026e | 68.51 | 21,69 |
| 2025e | 42.15 | 35,25 |
| 2024e | 27.08 | 54,87 |
| 2023 | 26.77 | 55,51 |
| 2022 | 28.15 | 65,61 |
| 2021 | 35.02 | 66,33 |
| 2020 | 26.63 | 71,24 |
| 2019 | 28.9 | 78,79 |
| 2018 | 29.35 | 80,51 |
| 2017 | 31.14 | 65,48 |
| 2016 | 32.16 | 76,59 |
| 2015 | 37.67 | 72,31 |
| 2014 | 35.01 | 76,52 |
| 2013 | 38.03 | 71,08 |
| 2012 | 46.56 | 68,26 |
| 2011 | 41.99 | 70,23 |
| 2010 | 54.05 | 71,21 |
| 2009 | 51.15 | 66,73 |
| 2008 | 40.37 | 64,87 |
| 2007 | 39.3 | 65,70 |
| 2006 | 27.19 | 52,59 |
| 2005 | 15.03 | 48,64 |
| 2004 | 18.82 | 43,30 |
Stereotaxis Revenue, EBIT, Net Income US85916J4094 · A1J09L
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Stereotaxis, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Stereotaxis from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Stereotaxis’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Stereotaxis. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Stereotaxis’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Stereotaxis’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Stereotaxis’s growth potential.
Stereotaxis Revenue, EBIT and net profit per share
| Date | Stereotaxis Revenue | Stereotaxis EBIT | Stereotaxis Net Income |
|---|---|---|---|
| 2026e | 68.51 M undefined | -2.86 M undefined | -9.5 M undefined |
| 2025e | 42.15 M undefined | -15.2 M undefined | -15.98 M undefined |
| 2024e | 27.08 M undefined | -19.25 M undefined | -21.16 M undefined |
| 2023 | 26.77 M undefined | -21.84 M undefined | -22.06 M undefined |
| 2022 | 28.15 M undefined | -18.78 M undefined | -19.64 M undefined |
| 2021 | 35.02 M undefined | -12.89 M undefined | -12.06 M undefined |
| 2020 | 26.63 M undefined | -6.71 M undefined | -8.02 M undefined |
| 2019 | 28.9 M undefined | -4.83 M undefined | -6.02 M undefined |
| 2018 | 29.35 M undefined | -2.46 M undefined | -1.32 M undefined |
| 2017 | 31.14 M undefined | -5.92 M undefined | -7.32 M undefined |
| 2016 | 32.16 M undefined | -6.42 M undefined | -11.8 M undefined |
| 2015 | 37.67 M undefined | -5.41 M undefined | -7.35 M undefined |
| 2014 | 35.01 M undefined | -5.38 M undefined | -5.2 M undefined |
| 2013 | 38.03 M undefined | -8.84 M undefined | -68.76 M undefined |
| 2012 | 46.56 M undefined | -10.63 M undefined | -9.24 M undefined |
| 2011 | 41.99 M undefined | -31.94 M undefined | -32.03 M undefined |
| 2010 | 54.05 M undefined | -18.96 M undefined | -19.92 M undefined |
| 2009 | 51.15 M undefined | -23.84 M undefined | -27.49 M undefined |
| 2008 | 40.37 M undefined | -41.02 M undefined | -43.89 M undefined |
| 2007 | 39.3 M undefined | -47.37 M undefined | -48.12 M undefined |
| 2006 | 27.19 M undefined | -46.67 M undefined | -45.72 M undefined |
| 2005 | 15.03 M undefined | -41.08 M undefined | -43.56 M undefined |
| 2004 | 18.82 M undefined | -27.42 M undefined | -27.26 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2004 | 18.82 M USD | -27.42 M USD | -27.26 M USD |
| 2005 | 15.03 M USD | -41.08 M USD | -43.56 M USD |
| 2006 | 27.19 M USD | -46.67 M USD | -45.72 M USD |
| 2007 | 39.3 M USD | -47.37 M USD | -48.12 M USD |
| 2008 | 40.37 M USD | -41.02 M USD | -43.89 M USD |
| 2009 | 51.15 M USD | -23.84 M USD | -27.49 M USD |
| 2010 | 54.05 M USD | -18.96 M USD | -19.92 M USD |
| 2011 | 41.99 M USD | -31.94 M USD | -32.03 M USD |
| 2012 | 46.56 M USD | -10.63 M USD | -9.24 M USD |
| 2013 | 38.03 M USD | -8.84 M USD | -68.76 M USD |
| 2014 | 35.01 M USD | -5.38 M USD | -5.2 M USD |
| 2015 | 37.67 M USD | -5.41 M USD | -7.35 M USD |
| 2016 | 32.16 M USD | -6.42 M USD | -11.8 M USD |
| 2017 | 31.14 M USD | -5.92 M USD | -7.32 M USD |
| 2018 | 29.35 M USD | -2.46 M USD | -1.32 M USD |
| 2019 | 28.9 M USD | -4.83 M USD | -6.02 M USD |
| 2020 | 26.63 M USD | -6.71 M USD | -8.02 M USD |
| 2021 | 35.02 M USD | -12.89 M USD | -12.06 M USD |
| 2022 | 28.15 M USD | -18.78 M USD | -19.64 M USD |
| 2023 | 26.77 M USD | -21.84 M USD | -22.06 M USD |
| 2024e | 27.08 M USD | -19.25 M USD | -21.16 M USD |
| 2025e | 42.15 M USD | -15.2 M USD | -15.98 M USD |
| 2026e | 68.51 M USD | -2.86 M USD | -9.5 M USD |
Stereotaxis stock margins US85916J4094 · A1J09L
The Stereotaxis margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Stereotaxis. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Stereotaxis.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Stereotaxis's sales revenue. A higher gross margin percentage indicates that the Stereotaxis retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Stereotaxis's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Stereotaxis's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Stereotaxis's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Stereotaxis. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Stereotaxis's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Stereotaxis Margin History
| Stereotaxis Gross margin | Stereotaxis Profit margin | Stereotaxis EBIT margin | Stereotaxis Profit margin |
|---|---|---|---|
| 2026e | 55.51 % | -4.17 % | -13.86 % |
| 2025e | 55.51 % | -36.06 % | -37.9 % |
| 2024e | 55.51 % | -71.09 % | -78.12 % |
| 2023 | 55.51 % | -81.58 % | -82.39 % |
| 2022 | 65.61 % | -66.71 % | -69.77 % |
| 2021 | 66.33 % | -36.81 % | -34.44 % |
| 2020 | 71.24 % | -25.2 % | -30.12 % |
| 2019 | 78.79 % | -16.71 % | -20.83 % |
| 2018 | 80.51 % | -8.38 % | -4.5 % |
| 2017 | 65.48 % | -19.01 % | -23.51 % |
| 2016 | 76.59 % | -19.96 % | -36.69 % |
| 2015 | 72.31 % | -14.36 % | -19.51 % |
| 2014 | 76.52 % | -15.37 % | -14.85 % |
| 2013 | 71.08 % | -23.24 % | -180.8 % |
| 2012 | 68.26 % | -22.83 % | -19.85 % |
| 2011 | 70.23 % | -76.07 % | -76.28 % |
| 2010 | 71.21 % | -35.08 % | -36.85 % |
| 2009 | 66.73 % | -46.61 % | -53.74 % |
| 2008 | 64.87 % | -101.61 % | -108.72 % |
| 2007 | 65.7 % | -120.53 % | -122.44 % |
| 2006 | 52.59 % | -171.64 % | -168.15 % |
| 2005 | 48.64 % | -273.32 % | -289.82 % |
| 2004 | 43.3 % | -145.7 % | -144.85 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2004 | 43.3 % | -145.7 % | -144.85 % |
| 2005 | 48.64 % | -273.32 % | -289.82 % |
| 2006 | 52.59 % | -171.64 % | -168.15 % |
| 2007 | 65.7 % | -120.53 % | -122.44 % |
| 2008 | 64.87 % | -101.61 % | -108.72 % |
| 2009 | 66.73 % | -46.61 % | -53.74 % |
| 2010 | 71.21 % | -35.08 % | -36.85 % |
| 2011 | 70.23 % | -76.07 % | -76.28 % |
| 2012 | 68.26 % | -22.83 % | -19.85 % |
| 2013 | 71.08 % | -23.24 % | -180.8 % |
| 2014 | 76.52 % | -15.37 % | -14.85 % |
| 2015 | 72.31 % | -14.36 % | -19.51 % |
| 2016 | 76.59 % | -19.96 % | -36.69 % |
| 2017 | 65.48 % | -19.01 % | -23.51 % |
| 2018 | 80.51 % | -8.38 % | -4.5 % |
| 2019 | 78.79 % | -16.71 % | -20.83 % |
| 2020 | 71.24 % | -25.2 % | -30.12 % |
| 2021 | 66.33 % | -36.81 % | -34.44 % |
| 2022 | 65.61 % | -66.71 % | -69.77 % |
| 2023 | 55.51 % | -81.58 % | -82.39 % |
| 2024e | 55.51 % | -71.09 % | -78.12 % |
| 2025e | 55.51 % | -36.06 % | -37.9 % |
| 2026e | 55.51 % | -4.17 % | -13.86 % |
Stereotaxis Aktienanalyse
What does Stereotaxis do?
Stereotaxis Inc, based in St. Louis, Missouri, is a company that specializes in the development and marketing of advanced instruments and services in magnetic resonance imaging (MRI) and electrophysiology (EP). The company was founded in 1990 and its mission is to improve the accuracy, safety, and efficiency of MRI and EP procedures. The business model of Stereotaxis is based on providing a comprehensive range of systems, instruments, and services to support hospitals and clinics in performing MRI and EP procedures. The company focuses on developing innovative technologies and solutions to improve clinical outcomes and provide the best possible treatment for patients. The company has four main divisions: magnetic resonance imaging (MRI), electrophysiology (EP), cardiovascular diagnostics, and cardiology. In the MRI division, the company offers a variety of instruments and systems specifically designed for MRI procedures. This includes magnetic field control systems, imaging systems, sample collection and analysis instruments, and controls to make MRI procedures more efficient. In the electrophysiology division, Stereotaxis offers instruments and systems that facilitate the navigation and control of medical devices during EP procedures. This includes magnetic field controls and other technologies to improve the accuracy of catheter placement and increase safety during procedures. Stereotaxis's cardiovascular diagnostics division offers various services and technologies that facilitate the performance of cardiology procedures. This includes a comprehensive diagnostic platform that allows for the analysis of heart images. The cardiology division of Stereotaxis offers a comprehensive range of solutions to improve the performance of cardiology procedures in cardiology clinics and hospitals. This includes a range of technologies to improve the diagnosis and treatment of heart diseases. In recent years, Stereotaxis has developed a variety of innovative solutions and technologies to improve the performance of MRI and EP procedures. One example is Robotic Magnetic Navigation, a technology developed by the company to improve the accuracy and safety of EP procedures. This technology allows doctors to improve the navigation and control of catheters during procedures, thereby providing patients with increased treatment safety. Another example is Stereotaxis's Odyssey platform, a solution developed to enable real-time connectivity between various medical devices. This allows doctors to access a variety of information during procedures and make the performance of procedures more efficient. Overall, Stereotaxis has an impressive track record in the development and marketing of advanced solutions and technologies in the MRI and EP industry in recent years. With its innovative technology and comprehensive range of instruments and services, the company is well positioned to continue playing a key role in healthcare in the future. Stereotaxis ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Stereotaxis's Sales Figures
The sales figures of Stereotaxis originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Stereotaxis’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Stereotaxis's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Stereotaxis’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Stereotaxis stock
How much was the turnover of the company Stereotaxis compared to the previous year?
The revenue of Stereotaxis has increased by 1.16% increased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Stereotaxis?
The revenue of Stereotaxis is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Stereotaxis measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Stereotaxis so important for investors?
The revenue of Stereotaxis is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Stereotaxis pay?
Over the past 12 months, Stereotaxis paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Stereotaxis is expected to pay a dividend of 0 USD.
What is the dividend yield of Stereotaxis?
The current dividend yield of Stereotaxis is .
When does Stereotaxis pay dividends?
Stereotaxis pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Stereotaxis?
Stereotaxis paid dividends every year for the past 0 years.
What is the dividend of Stereotaxis?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Stereotaxis located?
Stereotaxis is assigned to the 'Health' sector.
Wann musste ich die Aktien von Stereotaxis kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Stereotaxis from 11/20/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/20/2024.
When did Stereotaxis pay the last dividend?
The last dividend was paid out on 11/20/2024.
What was the dividend of Stereotaxis in the year 2023?
In the year 2023, Stereotaxis distributed 0 USD as dividends.
In which currency does Stereotaxis pay out the dividend?
The dividends of Stereotaxis are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Stereotaxis
Our stock analysis for Stereotaxis Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Stereotaxis Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
